A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which aims at improving infection management and thus the survival rate of patients.
Mpox, formerly known as monkeypox, is a rare viral disease that is spread through physical contact between people.
A rapid spike in cases of a potentially deadly, drug-resistant fungus has concerned public health officials across the nation. But a team of Southern Nevada researchers hope their new study applying wastewater surveillance can help health officials get a step ahead of this emerging global public health threat.
Application deadline: March 31
Preserving and restoring natural habitats could prevent pathogens that originate in wildlife from spilling over into domesticated animals and humans, according to two new companion studies.
The Harvard Medical School-led Massachusetts Consortium on Pathogen Readiness will play a central role in genomic surveillance and education on emerging and novel pathogens under a new $25 million CDC grant awarded to the Massachusetts Department of Public Health to establish the New England Pathogen Genomics Center of Excellence (PGCoE).
One suggested way to save humankind in the event of a deadly pandemic or other extreme global catastrophe is establishing a safe refuge – on an island or in such far-out places as the moon or under water — where a portion of the human population can stay alive.
Ted Ross, Ph.D., has been appointed Global Director of Vaccine Development at Cleveland Clinic.
In this newly created role, he will lead the development of novel vaccine platforms for a variety of infectious diseases, including influenza, HIV and COVID-19. A highly renowned scientist with expertise in virology, vaccines, immunology and microbiology, Dr. Ross’ research focuses on the design of new vaccines and the implementation of new vaccine trials.
Scientists at the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) have recorded the first North American case of a harmful phytoplasma disease known for its threat to fruit, vegetable and ornamental crops in South America and the Middle East. These same crops are economically important to Florida and in parts of the U.S. To make matters worse, scientists confirmed the host for the disease to be one of the most noxious and rapidly spreading weeds commonly found in a wide range of environments throughout the United States and into Canada.
Four San Antonio research institutes are collaborating to develop treatments against Nipah virus before it spreads. The World Health Organization has named Nipah virus a priority disease in need of urgent research and development because no approved vaccines or treatments exist.
Scientists at Oak Ridge National Laboratory and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in medicine, industry and agriculture.
Researchers are finding new details on the complex dynamics involved in how organisms sense an infection from pathogens. The researchers found that worms can sense changes in their metabolism in order to unleash protective defenses, even if they don’t directly sense an incursion from pathogens.
Armonk, N.Y. and Cleveland, OH, March 30, 2021: Cleveland Clinic and IBM have announced a planned 10-year partnership to establish the Discovery Accelerator, a joint Cleveland Clinic – IBM center with the mission of fundamentally advancing the pace of discovery in healthcare and life sciences through the use of high performance computing on the hybrid cloud, artificial intelligence (AI) and quantum computing technologies.
A research team from the National University of Singapore and the National University Hospital has developed a reusable protective barrier which lowers the risk of frontline healthcare workers being exposed to COVID-19 via droplets and aerosols when they look after patients.
Cleveland Clinic is establishing the Center for Global and Emerging Pathogens Research to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.
The new center has been in the planning stages for 18 months and will span Cleveland Clinic’s Lerner Research Institute and the soon-to-open Cleveland Clinic Florida Research and Innovation Center (FRIC) in Port St. Lucie, Florida.
Los Alamos National Laboratory biosecurity and public health expert Dr. Jeanne Fair is available for explaining emerging diseases such as coronavirus in understandable terms. For 25 years Dr. Fair has been working to understand how and why microbes may jump…